Cell Transplantation (May 2011)

Potential of Skin Fibroblasts for Application to Anterior Cruciate Ligament Tissue Engineering

  • Pierrot Tremblay,
  • Réjean Cloutier,
  • Jean Lamontagne,
  • Anne-Marie Belzil,
  • Anne-Marie Larkin,
  • Luc Chouinard,
  • Stéphane Chabaud,
  • Sheila Laverty,
  • Bertrand Lussier,
  • Francine Goulet Ph.D.

DOI
https://doi.org/10.3727/096368910X536482
Journal volume & issue
Vol. 20

Abstract

Read online

Fibroblasts isolated from skin and from anterior cruciate ligament (ACL) secrete type I and type III collagens in vivo and in vitro. However, it is much easier and practical to obtain a small skin biopsy than an ACL sample to isolate fibroblasts for tissue engineering applications. Various tissue engineering strategies have been proposed for torn ACL replacement. We report here the results of the implantation of bioengineered ACLs (bACLs), reconstructed in vitro using a type I collagen scaffold, anchored with two porous bone plugs to allow bone–ligament–bone surgical engraftment. The bACLs were seeded with autologous living dermal fibroblasts, and grafted for 6 months in goat knee joints. Histological and ultrastructural observations ex vivo demonstrated a highly organized ligamentous structure, rich in type I collagen fibers and cells. Grafts' vascularization and innervation were observed in all bACLs that were entirely reconstructed in vitro. Organized Sharpey's fibers and fibrocartilage, including chondrocytes, were present at the osseous insertion sites of the grafts. They showed remodeling and matrix synthesis postimplantation. Our tissue engineering approach may eventually provide a new solution to replace torn ACL in humans.